Thiruvananthapuram, July 14: Kerala’s first comprehensive Bio-safety Level-3 Laboratory at the Rajiv Gandhi Centre for Biotechnology (RGCB) here has been approved by Department of Biotechnology, Government of India, to carry out research activities involving live infectious organisms classified as BSL-3 agents, such as SARS-CoV-2 and influenza.
RGCB’s BSL-3 modular facility has been set up at its new campus located at Aakkulam.
RGCB Director Prof. Chandrabhas Narayana said the new BSL-3 Lab will foster collaborations across industry, academia and clinical partners to develop novel drugs and vaccines against pathogens of regional relevance.
“The laboratory will also serve as a core platform to undertake ground-breaking research on zoonotic infectious agents and pathogen adaptations towards future pandemic preparedness,” he added.
Bengaluru, India – May 02, 2024 – Agora, Inc.
Gurugram, India – October 11, 2023: Samsung announced exciting offers
Bangalore, 10th October 2023: The Nokia G42 5G (16GB+256G
Bengaluru, October 10, 2023 IN-SPACe (Indian National Space Promotion and
India – April 30, 2024 – Solitario, the premier destination for luxury lab-grown diamo
Mumbai - National, 29th April 2024: Greenply Industries Limited, a pioneer in the interior infrastructu
Bengaluru, 29 April 2024: Zepp Health, a global provider of smart wearables and health technology, has announced the launch o